IP Library › Granted Patent US 11,826,253
Granted Patent B2
US 11,826,253 · App. 16/934,853 · Granted Nov 28, 2023

Percutaneous temporary aortic valve

Inventor: Paul C. Ho (Honolulu, HI)
Assignee: HOCOR CARDIOVASCULAR TECHNOLOGIES LLC
A61F2/246A61F2/2412A61F2/2427A61F2/2454A61F2/2466A61F2230/0008A61F2230/0067A61F2250/0059
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,826,253
App. No.
16/934,853
Granted
Nov 28, 2023
Kind
B2
Abstract

Methods and apparatuses for regulating aortic regurgitation are provided. A catheter shaft is advanced through vasculature so that a flexible occluding membrane coupled to the catheter shaft is positioned within the aorta, typically the ascending aorta above the Sinus of Valsalva and coronary ostia. Blood flow in the aorta causes the flexible occluding membrane to alternate between an expanded occluding configuration while in diastole and a collapsed lesser occluding configuration is systole. The flexible occluding membrane thereby acts as a temporary aortic valve. The flexible occluding membrane is generally conical in shape, with the tip of the cone disposed closer to the aorta than the proximal rim. In diastole, blood flow expands the flexible occluding membrane so that the proximal rim apposes the inner wall of the aorta. The flexible occluding membrane will have one or more openings to allow perfusion of the coronary arteries in diastole.

Claims (17)

1. A temporary cardiovascular valve apparatus comprising:

a catheter shaft adapted for placement within an artery of a patient; and

a flexible membrane having a lateral side coupled to the catheter shaft, a proximal end, a distal end, and an opening at the distal end,

wherein the flexible membrane is adapted to, when placed within the artery with the distal end of the flexible membrane oriented toward blood flow within the artery, alternate between an expanded occluding configuration and a collapsed configuration in response to the blood flow and in synchrony with ventricular diastole and systole,

wherein the flexile membrane inhibits the blood flow within the artery when in the expanded occluding configuration and lessens inhibition of the blood flow when in the collapsed configuration, and

wherein the opening allows blood perfusion therethrough when the membrane is in the expanded occluding configuration within the artery.

2. The temporary cardiovascular valve apparatus of claim 1 , wherein the opening is positioned at substantially a center of the membrane.

3. The temporary cardiovascular valve apparatus of claim 2 , wherein the center of the membrane is disposed at the distal end of the membrane.

4. The temporary cardiovascular valve apparatus of claim 1 , wherein the opening is positioned at a location offset from a center of the membrane.

5. The temporary cardiovascular valve apparatus of claim 1 , wherein the membrane has a plurality of openings to allow blood perfusion therethrough when in the expanded occluding configuration.

6. The temporary cardiovascular valve apparatus of claim 1 , wherein the opening has a cross-sectional size of 50% or less, 45% or less, 40% or less, 35% or less, 30% or less, 25% or less, 20% or less, 15% or less, 10% or less, or 5% or less of the artery.

7. The temporary cardiovascular valve apparatus of claim 1 , wherein the catheter shaft comprises a distal anchoring loop having an expanded curved configuration for anchoring the catheter shaft and the membrane in the aorta and a collapsed, straightened configuration for advancement into or retraction from the artery.

8. The temporary cardiovascular valve apparatus of claim 1 , wherein the membrane has a conical shape.

9. The temporary cardiovascular valve apparatus of claim 8 , wherein the conically-shaped membrane comprises an annular proximal lip adapted to appose an inner wall of the artery when the membrane is in the expanded occluding configuration.

10. The temporary cardiovascular valve apparatus of claim 1 , wherein the membrane is adapted to be positioned within an ascending aorta of the patient to provide occlusion therein.

11. The temporary cardiovascular valve apparatus of claim 10 , wherein the membrane is adapted to be positioned within the ascending aorta just above the Sinus of Valsalva and coronary ostia.

12. The temporary cardiovascular valve apparatus of claim 10 , wherein the membrane is adapted to be positioned within the ascending aorta between the coronary ostia and the brachiocephalic artery.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 7, 2026
From: HO, PAUL C.
To: HOCOR CARDIOVASCULAR TECHNOLOGIES, LLC
Reel/Frame 074294/0052 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 21, 2020
From: HO, PAUL C.
To: HOCOR CARDIOVASCULAR TECHNOLOGIES LLC
Reel/Frame 053272/0566 →
Continuity (4)
Continuation 15821056 · Nov 22, 2017
Continuation 15083768 · Mar 29, 2016
Provisional Application 62140111 · Mar 30, 2015
Related Publication 20210169641A1 · Jun 10, 2021
Cited By (1)
US 12,640,270